CNA landscape of HER2-negative breast cancer during administration of taxane-containing schemes of neoadjuvant chemotherapy

Introduction. Evaluation of when and how to include taxanes in preoperative chemotherapy is becoming more important in the era when molecular and genetic approaches allow to develop biologically targeted therapeutic medications and select patients who can benefit from certain cytotoxic agents.Aim. T...

Full description

Saved in:
Bibliographic Details
Main Authors: M. K. Ibragimova, E. A. Kravtsova, M. M. Tsyganov, N. V. Litviakov
Format: Article
Language:Russian
Published: ABV-press 2025-04-01
Series:Успехи молекулярной онкологии
Subjects:
Online Access:https://umo.abvpress.ru/jour/article/view/757
Tags: Add Tag
No Tags, Be the first to tag this record!